• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Discovery Laboratories Inc

+ Add to Watchlist


1.9200 USD 0.0400 2.13%

As of 20:10:00 ET on 10/23/2014.

Snapshot for Discovery Laboratories Inc (DSCO)

Open: 1.9200 Day's Range: 1.8800 - 2.0100 Volume: 434,250
Previous Close: 1.8800 52wk Range: 1.5100 - 2.7700 1-Yr Rtn: -17.95%

Stock Chart for DSCO

No chart data available.
  • DSCO:US 1.9150
  • 1D
  • 1M
  • 1Y
Interactive DSCO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DSCO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6600
Est. EPS (USD) (12/2014) -0.5400
Est. PEG Ratio -
Market Cap (M USD) 163.60
Shares Outstanding (M) 85.21
30 Day Average Volume 256,940
Price/Book (mrq) 4.1727
Price/Sale (ttm) 125.3064
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DSCO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DSCO

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.

John G CooperPresident/CEOJohn A TattorySenior VP/CFO
Thomas F MillerSenior VP/COORussell ClaytonSenior VP:Research & Dev
More Company Profile & Key Executives for DSCO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil